Ophthalmic formulations of methotrexate

The present disclosure provides formulations of methotrexate for ocular administration, including intravitreal administration, and the use of the formulations for the treatment of proliferative vitreoretinopathy (PVR), intraocular lymphoma (e.g., PVRL), and intraocular inflammation. 本公开提供了用于眼部施用(包括玻...

Full description

Saved in:
Bibliographic Details
Main Authors MAHATA SUNIL G, ELLIOTT DECLAN, SALPOTEDA PAULO, STRYJEWSKI THOMAS
Format Patent
LanguageChinese
English
Published 29.04.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present disclosure provides formulations of methotrexate for ocular administration, including intravitreal administration, and the use of the formulations for the treatment of proliferative vitreoretinopathy (PVR), intraocular lymphoma (e.g., PVRL), and intraocular inflammation. 本公开提供了用于眼部施用(包括玻璃体内施用)的甲氨蝶呤制剂，以及所述制剂用于治疗增殖性玻璃体视网膜病(PVR)、眼内淋巴瘤(例如PVRL)和眼内炎症的用途。
Bibliography:Application Number: CN202080063801